Inactive Instrument

All News YM BioSciences Inc.

Equities

YM Biosciences : Raises US$80.5 Million from Public Offering	12-02-29	PU
YM Biosciences : Prices $70 Million Public Offering of Common Shares	12-02-24	PU
YM Biosciences : Announces Proposed Public Offering of Common Shares	12-02-23	PU
YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	12-02-09	PU
YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	11-12-12	PU
YM Biosciences : Comments on Unusual Market Activity	11-11-22	PU
YM Biosciences : Reports Operational and Financial Results for the First Quarter of Fiscal 2012	11-11-11	PU
YM Biosciences : to Report Updated Phase I/II Data for CYT387 at ASH 2011	11-11-07	PU
YM Biosciences : Nimotuzumab Results Reported at SIOP Conference	11-10-31	PU
YM Biosciences : Initiates Phase II BID Trial with CYT387 in Myelofibrosis	11-09-28	PU
YM Biosciences : CORRECTION FROM SOURCE: YM BioSciences Reports Fiscal 2011 Year End Operational and Financial Results	11-09-23	PU
YM BioSciences Inc. (USA) : Yellowhead Mining Inc. Announces Voting Results of 2011 Annual and Special Meeting	11-06-02	PU
YM BioSciences Inc. (USA) : Yellowhead Mining Inc. Appoints VP Environment, Community & First Nations Relations; Also Manager, Corporate Administration	11-06-01	PU
YM BioSciences Inc. (USA) : YM BioSciences Provides Update on the Development Program for Nimotuzumab	11-05-30	PU

No results for this search